TWD 21.45
(-13.86%)
Year | Net Debt | Net Debt Growth |
---|---|---|
2023 | 74.05 Million TWD | -79.32% |
2022 | 358.12 Million TWD | -15.93% |
2021 | 425.96 Million TWD | 25.14% |
2020 | 340.38 Million TWD | 53.32% |
2019 | 222.01 Million TWD | 0.0% |
Year | Net Debt | Net Debt Growth |
---|---|---|
2024 Q1 | 74.92 Million TWD | 1.19% |
2024 Q2 | 67.08 Million TWD | 55.45% |
2023 Q3 | 68.74 Million TWD | -78.47% |
2023 FY | 74.05 Million TWD | -79.32% |
2023 Q4 | 74.05 Million TWD | 7.71% |
2023 Q2 | 319.3 Million TWD | 3.37% |
2023 Q1 | 308.91 Million TWD | -13.74% |
2022 Q4 | 358.12 Million TWD | 1.49% |
2022 FY | 358.12 Million TWD | -15.93% |
2022 Q3 | 352.88 Million TWD | 0.0% |
2021 FY | 425.96 Million TWD | 25.14% |
2020 FY | 340.38 Million TWD | 53.32% |
2019 FY | - TWD | 0.0% |
Name | Net Debt | Net Debt Difference |
---|---|---|
Anti-Microbial Savior BioteQ Co., Ltd | -77.04 Million TWD | 196.115% |
SYN-TECH Chem. & Pharm. Co., Ltd. | -264.16 Million TWD | 128.032% |
Level Biotechnology Inc. | -453.9 Million TWD | 116.314% |
Sagittarius Life Science Corp | -120.57 Million TWD | 161.417% |
NeoCore Technology Co., Ltd. | -196.39 Million TWD | 137.705% |
TaiMed Biologics Inc. | 499.84 Million TWD | 85.185% |
GlycoNex Incorporation | -148.56 Million TWD | 149.844% |
VBI | -25.31 Million TWD | 392.507% |
GeneReach Biotechnology Corp. | 40.26 Million TWD | -83.905% |
Taiwan Advance Bio-Pharmaceutical Inc. | 137.99 Million TWD | 46.338% |
SynCore Biotechnology Co.,Ltd | -262.58 Million TWD | 128.201% |
Genomics BioSci & Tech. Co.,Ltd. | 30.57 Million TWD | -142.171% |
Visgeneer Inc. | 31.28 Million TWD | -136.706% |
Mycenax Biotech Inc. | 207 Million TWD | 64.228% |
Sunmax Biotechnology Co., Ltd. | -680.6 Million TWD | 110.88% |
G&E Herbal Biotechnology Co., Ltd. | -134.25 Million TWD | 155.158% |
Neith Corporation | -150.31 Million TWD | 149.265% |
Medigen Vaccine Biologics Corporation | 621.53 Million TWD | 88.086% |
TaiwanJ Pharmaceuticals Co., Ltd. | -57.65 Million TWD | 228.431% |
Enimmune corporation | -314.15 Million TWD | 123.571% |
TaiRx, Inc. | -147.86 Million TWD | 150.079% |
CHO Pharma, Inc. | -203.79 Million TWD | 136.337% |
EirGenix Inc. | -4.58 Billion TWD | 101.614% |
BioLASCO Taiwan Co., Ltd. | -84.76 Million TWD | 187.362% |
Sunny Pharmtech Inc. | 120.87 Million TWD | 38.736% |
Lin BioScience, Inc. | -3.21 Billion TWD | 102.301% |
BioGend Therapeutics Co., Ltd. | -317.41 Million TWD | 123.329% |
Feng Chi Biotech Corp. | -19.81 Million TWD | 473.75% |
Bio Preventive Medicine Corp. | 31.8 Million TWD | -132.799% |
Lukas Biomedical Inc. | 50.75 Million TWD | -45.899% |
RBC Bioscience Corporation | 422.18 Million TWD | 82.46% |
BiOptic Inc. | 12.59 Million TWD | -488.08% |
BRIM Biotechnology, Inc. | -944.4 Million TWD | 107.841% |
Shine-On BioMedical Co.,Ltd. | -101.48 Million TWD | 172.967% |
Great Novel Therapeutics Biotech & Medicals | -165.17 Million TWD | 144.832% |
Syngen Biotech Co.,Ltd. | 314.87 Million TWD | 76.482% |
Advagene Biopharma Co., Ltd. | -64.32 Million TWD | 215.127% |
NaviFUS Corp. | -123.12 Million TWD | 160.141% |
Sinew Pharma Inc. | -160.34 Million TWD | 146.182% |
Andros Pharmaceuticals Co.,Ltd | -241.89 Million TWD | 130.613% |
Greenyn Biotechnology Co., Ltd | -337.37 Million TWD | 121.949% |
Lumosa Therapeutics Co., Ltd. | -412.63 Million TWD | 117.946% |
AP Biosciences Inc | -196.52 Million TWD | 137.68% |
Medigen Biotechnology Corp. | 688.73 Million TWD | 89.248% |
3D Global Biotech Inc. | -11.43 Million TWD | 747.469% |
Pharmosa Biopharm Inc. | -829.69 Million TWD | 108.925% |
Intech Biopharm Corporation | 1.35 Billion TWD | 94.544% |
Oneness Biotech Co., Ltd. | -414.87 Million TWD | 117.849% |
Eusol Biotech Co.,Ltd. | -209.33 Million TWD | 135.374% |
TWi Biotechnology, Inc. | -143.86 Million TWD | 151.473% |
Ever Supreme Bio Technology Co., Ltd | -330.54 Million TWD | 122.403% |
TCI GENE Inc. | -689.25 Million TWD | 110.744% |
MegaPro Biomedical Co., Ltd | -118.93 Million TWD | 162.26% |
Senhwa Biosciences, Inc. | -1.3 Billion TWD | 105.656% |
Taiwan Bio Therapeutics Co., Ltd | 20.48 Million TWD | -261.524% |
NatureWise Biotech & Medicals Corporation | -101.87 Million TWD | 172.692% |
PharmaEngine, Inc. | -860.8 Million TWD | 108.602% |
Savior Lifetec Corporation | -812.54 Million TWD | 109.113% |
TaiGen Biopharmaceuticals Holdings Limited | -299.96 Million TWD | 124.686% |
OBI Pharma, Inc. | -398.22 Million TWD | 118.595% |
Meribank Biotech Co., Ltd | -365.41 Million TWD | 120.265% |
Acepodia, Inc. | -6.02 Billion TWD | 101.23% |
Caliway Biopharmaceuticals Co., Ltd. | -3.4 Billion TWD | 102.177% |